Antibiotic Use in Pediatric Dengue Cases in Taiwan: A National Administrative Database Analysis
The American Journal of Tropical Medicine and Hygiene · 2025
DOI: 10.4269/ajtmh.24-0414 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2025. Verfasst von Yi-Jung Shen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hospital and Health Care Administration, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Dengue. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nonspecific dengue clinical manifestations lead to avoidable antibiotic use. We describe antibiotic use in confirmed pediatric dengue cases and associated healthcare utilization and medical costs, including from antibiotic-associated adverse drug events (ADEs). From Taiwanese national administrative databases, children with confirmed dengue between 2009 and 2015 who were younger than 18 years old, without bacterial infection, and who were prescribed antibiotics a week before or after laboratory diagnosis were propensity score matched and compared with nonrecipients, using regression models for ADEs and medical care expenditures. A total of 1,959 out of 6,938 children (28.2%) with confirmed dengue without bacterial infection received antibiotics. Recipients were more likely to incur emergency department visits (odds ratio [OR]: 3.16; 95% CI: 2.62–3.81), hospitalizations (OR: 4.20; 95% CI: 3.48–5.07), and higher predicted medical care expenditures (new Taiwan dollar [NTD] $16,914 versus NTD $14,104) in a 30-day follow-up period. They also had significantly higher odds of overall defined (OR: 1.72; 95% CI: 1.42–2.09), dermatologic-related (OR: 1.83; 95% CI: 1.36–2.46), and gastrointestinal-related (OR: 1.67; 95% CI: 1.31–2.12) ADEs. A substantial proportion of pediatric patients with dengue received potentially avoidable courses of antibiotics. Recipients were more likely to experience ADEs, incurring more medical care utilization and expenditures than untreated cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Hospital and Health Care Administration, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Health Law, Policy, and Management, School of Public Health, Boston University, Boston, Massachusetts.
- Institute of Public Health, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Office of the Deputy Superintendent, National Yang Ming Chiao Tung University Hospital, Yilan County, Taiwan.
- Takeda Vaccines Inc., Cambridge, Massachusetts.
Zitieren
APA
Shen, Y. J., Lien, C. E., Chou, Y. J., Huang, N., & Tsai, T. (2025). Antibiotic Use in Pediatric Dengue Cases in Taiwan: A National Administrative Database Analysis. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.24-0414
Vancouver
Shen YJ, Lien CE, Chou YJ, Huang N, Tsai T. Antibiotic Use in Pediatric Dengue Cases in Taiwan: A National Administrative Database Analysis. The American Journal of Tropical Medicine and Hygiene. 2025. doi:10.4269/ajtmh.24-0414
BibTeX
@article{Shen2025,
author = {Shen, Yi-Jung and Lien, Chia-En and Chou, Yiing-Jenq and Huang, Nicole and Tsai, Theodore},
title = {Antibiotic Use in Pediatric Dengue Cases in Taiwan: A National Administrative Database Analysis},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2025},
doi = {10.4269/ajtmh.24-0414}
}
EUVIMED